Abstract: 514 NEW INROADS DEFINING THE CARDIOMETABOLIC BENEFITS OF PPAR AGONISTS IN DIABETES AND INSULIN RESISTANCE
Watts, GVolume:
10
Language:
english
Journal:
Atherosclerosis Supplements
DOI:
10.1016/s1567-5688(09)70073-x
Date:
June, 2009
File:
PDF, 80 KB
english, 2009